Role of fluorodeoxyglucose positron emission tomography in the staging of patients with breast cancer candidated to surgery [2]

Annals of Oncology

Volumn 18, Issue 2, 2007, Pages 394-395

  Cardillo, Anna ^a   De Cicco, C ^a   Paganelli, G ^a   Ghisini, R ^a   Peruzzotti, G ^a   Balduzzi, A ^a   Goldhirsch, A ^a   Rotmensz, N ^a   Veronesi, P ^a   Luini, A ^a   Intra, M ^a   Colleoni, M ^a  

^a EUROPEAN INSTITUTE OF ONCOLOGY   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

BONE METASTASIS; BONE SCINTISCANNING; BREAST CANCER; CANCER STAGING; CANCER SURGERY; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; ECHOGRAPHY; HUMAN; LETTER; MAJOR CLINICAL STUDY; NUCLEAR MAGNETIC RESONANCE IMAGING; PATIENT CARE; PATIENT CODING; PATIENT REFERRAL; POSITRON EMISSION TOMOGRAPHY; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; THORAX RADIOGRAPHY;

EID: 33847317852     PISSN: 09237534     EISSN: 15698041     Source Type: Journal    
DOI: 10.1093/annonc/mdl354     Document Type: Letter

References (5)

1. Norum J, Andreassen T. Screening for metastatic disease in newly diagnosed breast cancer patients. What is cost-effective? Anticancer Res 2000; 20 (3B): 2193-2196.
2. Van der Hoeven JJ, Krak NC, Hoekstra OS et al. 18F-2-fluoro-2-deoxy-d-glucose positron emission tomography in staging of locally advanced breast cancer. J Clin Oncol 2004; 22 (7): 1253-1259.
3. Bellon JR, Livingston RB, Eubank WB et al. Evaluation of the internal mammary lymph nodes by FDG-PET in locally advanced breast cancer (LABC). Am J Clin Oncol 2004; 27 (4): 407-410.
4. Wahl RL. Current status of PET in breast cancer imaging, staging, and therapy. Semin Roentgenol 2001; 36 (3): 250-260.
5. Buck AK, Schirrmeister H, Mattfeldt T, Reske SN. Biological characterisation of breast cancer by means of PET. Eur J Nucl Med Mol Imaging 2004; 31 (Suppl 1): 80-87.